The Healthcare Sales & Marketing Network(R): Sales & Marketing News, Information and Networking for Medical Devices, Pharmaceuticals and Biotechnology.
Sales & Marketing News, Information and Networking for Medical Devices, Pharmaceuticals and Biotechnology.
Main Page: Medical News Roundups and more Medical Device and Biotech/Pharmaceutical News Medical Meetings and Conventions Calendar Message Boards for Medical Sales and Marketing Professionals, Distributors and Independent Sales Reps in Devices, Biopharmaceuticals and Diagnostics Medical Device Companies, Biotech/Pharmaceutical Companies, Distributors and Independent Sales Reps Members sections: News Roundups, News Archives, SuperSearch, Directory of Medical Sales and Marketing Professionals
Healthcare Sales & Marketing Network celebrates twelve years serving the medical device, biopharmaceutical and diagnostics community!
Share/Bookmark

 
 Roundups:   Bio/Pharma | Devices | Diagnostics | Cardiology | Oncology | Neuro | Ortho | FDA | Personnel | M&A
Generics | Interventional | Radiology | Regenerative | Endocrinology | Monitoring | Venture Capital


  
   
 Healthcare Industry NewsFeed
Search hints >>    
     
Thursday, September 2, 2010
ConvaTec Expands AQUACEL(R) Dressing Product Line With Introduction of New Ribbon Dressing
HSMN NewsFeed, 2 Sep 2010:   Devices, Wound Care
[ConvaTec, AQUACEL]

VA Puget Sound Facilities Standardize with FlexiPort(R) Disposable Cuffs, Reinforcing a Commitment to Patient Safety
HSMN NewsFeed, 2 Sep 2010:   Devices
[Welch Allyn, FlexiPort, blood pressure cuff, blood pressure]

Long Term Data Presented at ESC 2010 Further Support the Benefit of The CYPHER(R) Sirolimus Drug-Eluting Stent Compared to The ENDEAVOR(R) Zotarolimus-Eluting Stent in Important High-Risk Subgroups
HSMN NewsFeed, 2 Sep 2010:   Devices, Interventional Cardiology
[Cordis, CYPHER, Sirolimus, Drug Eluting Stent, Zotarolimus, Medtronic]

Cardiogenesis Comments on the STAR-Heart Study Presented at European Society of Cardiology (ESC) 2010 Congress
HSMN NewsFeed, 2 Sep 2010:   Regenerative Medicine, Devices, Cardiology
[Cardiogenesis, STAR-heart study, stem cell, heart failure, cardiomyopathy]

Pfizer to Acquire FoldRx Pharmaceuticals
HSMN NewsFeed, 1 Sep 2010:   Biopharmaceuticals, Mergers & Acquisitions
[Pfizer, FoldRx Pharmaceuticals]

GI Dynamics Announces Distribution Agreement with Elemental Healthcare for the EndoBarrier Gastrointestinal Liner
HSMN NewsFeed, 1 Sep 2010:   Devices, Distribution
[GI Dynamics, Elemental Healthcare, EndoBarrier]

Celator(R) Pharmaceuticals Raises $20 Million in Series D Financing
HSMN NewsFeed, 1 Sep 2010:   Biopharmaceuticals, Venture Capital
[Celator Pharmaceuticals]

InfraReDx Receives FDA Clearance for LipiScan IVUS Coronary Imaging System
HSMN NewsFeed, 1 Sep 2010:   Devices, Cardiology
[InfraReDx, LipiScan, IVUS Coronary Imaging, intravascular ultrasound]

Archimedes Pharma Receives European Marketing Authorisation for PecFent(R) for the Treatment of Breakthrough Cancer Pain
HSMN NewsFeed, 1 Sep 2010:   Biopharmaceuticals, Regulatory
[Archimedes Pharma, PecFent, fentanyl nasal spray, breakthrough cancer pain]

Inspire Names Robert Savel as Senior Vice President and Chief Technical Officer
HSMN NewsFeed, 1 Sep 2010:   Biopharmaceuticals, Personnel
[Inspire Pharmaceuticals]

Syneron Appoints New Chief Financial Officer
HSMN NewsFeed, 1 Sep 2010:   Devices, Personnel
[Syneron Medical]

Microplasmin Meets Primary Endpoint in Second Phase III Trial in VMA, Confirms Positive Findings of First Trial
HSMN NewsFeed, 1 Sep 2010:   Biopharmaceuticals, Ophthalmology
[ThromboGenics, microplasmin, vitreomacular adhesion]

New 2010 ESC Guidelines for Percutaneous Coronary Interventions Reinforce Importance of FFR in Treatment of Coronary Artery Disease
HSMN NewsFeed, 31 Aug 2010:   Devices, Interventional Cardiology
[St. Jude Medical, PressureWire, Fractional Flow Reserve]

Allergan, Inc. Receives FDA Approval for LUMIGAN(R) 0.01% as First-Line Therapy Indicated for the Reduction of Elevated Intraocular Pressure in Glaucoma Patients
HSMN NewsFeed, 31 Aug 2010:   Biopharmaceuticals, Ophthalmology, FDA
[Allergan, LUMIGAN, bimatoprost, intraocular pressure, glaucoma]

Quidel Announces FDA Clearance of Its RapidVue(R) hCG Pregnancy Lateral Flow Diagnostic Test
HSMN NewsFeed, 31 Aug 2010:   Diagnostics, FDA
[Quidel, RapidVue, hCG, human Chorionic Gonadotropin, pregnancy test]

Dr. Les Paul Joins Caris Life Sciences as Senior Vice President, Medical Affairs
HSMN NewsFeed, 31 Aug 2010:   Diagnostics, Personnel
[Caris Life Sciences]

Hill-Rom Appoints Scott Jeffers as Senior Vice President, Global Supply Chain
HSMN NewsFeed, 31 Aug 2010:   Devices, Personnel
[Hill-Rom]

Sunshine Heart Announces First Minimally Invasive Thoracotomy Procedures Performed for the C-Pulse(R) Heart Assist System
HSMN NewsFeed, 31 Aug 2010:   Devices, Cardiology
[Sunshine Heart, C-Pulse, Heart Assist, ventricular assist]

Swiss Breast Cancer Patient Becomes First in World to Receive Treatment Using Gated RapidArc from Varian Medical Systems
HSMN NewsFeed, 31 Aug 2010:   Devices, Oncology
[Varian Medical Systems, RapidArc, Gated RapidArc, radiotherapy]

Gary O'Hara Named Chief Technology Officer at Sanomedics
HSMN NewsFeed, 31 Aug 2010:   Devices, Personnel
[Sanomedics]

CORDIS Announces Results of Ten-Year CYPHER(R) Sirolimus-Eluting Coronary Stent Follow-Up
HSMN NewsFeed, 31 Aug 2010:   Devices, Interventional Cardiology
[Cordis, CYPHER, drug eluting stent, Sirolimus]

Rivaroxaban Successfully Demonstrated Non-Inferiority Compared to Standard of Care for the Prevention of Recurrent Venous Thromboembolism in Pivotal Phase 3 Study
HSMN NewsFeed, 31 Aug 2010:   Biopharmaceuticals
[J&JPRD, Johnson & Johnson, rivaroxaban, venous thromboembolism, DVT]

Meda acquires Alaven, a US specialty pharma company
HSMN NewsFeed, 30 Aug 2010:   Biopharmaceuticals, Mergers & Acquisitions
[Meda AB, Alaven]

Aptus Endosystems Completes $15 Million Series AA Financing
HSMN NewsFeed, 30 Aug 2010:   Devices, Venture Capital
[Aptus Endosystems, endovascular aneurysm repair]

Otonomy Closes $38.5 Million Series B Financing
HSMN NewsFeed, 30 Aug 2010:   Biopharmaceuticals, Venture Capital
[Otonomy]

King Pharmaceuticals Appoints Jeffrey Bailey Chief Commercial Officer
HSMN NewsFeed, 30 Aug 2010:   Biopharmaceuticals, Personnel
[King Pharmaceuticals]

Genzyme Confirms Receipt of Unsolicited Proposal
HSMN NewsFeed, 30 Aug 2010:   Biopharmaceuticals, Mergers & Acquisitions
[Genzyme, Sanofi-Aventis]

Easton Pharmaceuticals Inc. Announces Experienced CFO Appointment to Management Team
HSMN NewsFeed, 30 Aug 2010:   Biopharmaceuticals, Personnel
[Easton Pharmaceuticals]

AngioDynamics Expands Its VenaCure EVLTTM System to Offer Physicians Fewer Procedure Steps and a Faster Procedure Time
HSMN NewsFeed, 30 Aug 2010:   Devices
[AngioDynamics, VenaCure EVLT]

Toshiba Installs 1,000th MR System Worldwide
HSMN NewsFeed, 30 Aug 2010:   Devices, Radiology
[Toshiba America Medical Systems]

EndoGastric Solutions Completes $30 Million Financing Round
HSMN NewsFeed, 30 Aug 2010:   Devices, Surgery, Venture Capital
[EndoGastric Solutions, Natural Orifice Surgery]

U.K. Bariatric Surgeon Performs Europe's First ROSE Procedures Using USGI Medical's Incisionless Operating Platform(TM) (IOP)
HSMN NewsFeed, 30 Aug 2010:   Devices, Surgery
[USGI Medical, Incisionless Surgery, ROSE Procedure]

Teriflunomide Significantly Reduced Annualized Relapse Rate and was Well Tolerated in MS Patients
HSMN NewsFeed, 30 Aug 2010:   Biopharmaceuticals, Neurology
[Sanofi-aventis, multiple sclerosis, teriflunomide, TEMSO trial]

sanofi-aventis Announces Non-Binding Offer to Acquire Genzyme
HSMN NewsFeed, 29 Aug 2010:   Biopharmaceuticals, Mergers & Acquisitions
[sanofi-aventis, Genzyme]

Medical Action Industries Inc. Completes Acquisition of AVID Medical, Inc.
HSMN NewsFeed, 27 Aug 2010:   Devices, Mergers & Acquisitions
[Medical Action Industries, AVID Medical]

Exactech Acquires Minimally Invasive Spine Reconstruction Portfolio
HSMN NewsFeed, 27 Aug 2010:   Devices, Acquisitions, Orthopaedic, Neurosurgery
[Exactech, VertiFlex, Silverbolt, Pedicle Screw, spine surgery]

Novartis receives FDA approval of Tekamlo, a single-pill combination of aliskiren and amlodipine to treat high blood pressure
HSMN NewsFeed, 27 Aug 2010:   Biopharmaceuticals, Cardiology, FDA
[Novartis Pharmaceuticals, aliskiren, amlodipine, Tekamlo]

Genentech Provides Update on FDA Application for T-DM1
HSMN NewsFeed, 27 Aug 2010:   Biopharmaceuticals, Oncology, FDA
[Genentech, Roche Group, trastuzumab-DM1, T-DM1, HER2, armed antibody]






 
     

 

 

 HOME    •    NEWSFEED    •     MEETINGS & CONVENTIONS    •    FORUM    •    LINKS    •    TOP   
Copyright © 1998-2010 The Healthcare Sales & Marketing Network. All rights reserved.
The Healthcare Sales & Marketing Network is a registered trademark of Healthcare Sales & Marketing Network, LLC.
Powered by Redhat Enterprise Linux 4ES